Orchard Therapeutics PLC Price Prediction

ORTXDelisted Stock  USD 16.70  0.00  0.00%   
The relative strength index (RSI) of Orchard Therapeutics' stock price is slightly above 64. This indicates that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling a stock, making its price go up or down.

Oversold Vs Overbought


Orchard Therapeutics PLC stock price prediction is an act of determining the future value of Orchard Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Orchard Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Orchard Therapeutics and does not consider all of the tangible or intangible factors available from Orchard Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Orchard Therapeutics PLC, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether delisted stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Orchard Therapeutics based on different types of headlines from major news networks to social media. The Orchard stock price prediction module provides an analysis of price elasticity to changes in media outlook on Orchard Therapeutics over a specific investment horizon. Using Orchard Therapeutics hype-based prediction, you can estimate the value of Orchard Therapeutics PLC from the perspective of Orchard Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Orchard Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Orchard Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Orchard because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Orchard Therapeutics after-hype prediction price

  USD 16.7  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Orchard Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Orchard Therapeutics in the context of predictive analytics.
Band Projection (param)
LowerMiddle BandUpper
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Orchard Therapeutics. Your research has to be compared to or analyzed against Orchard Therapeutics' peers to derive any actionable benefits. When done correctly, Orchard Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Orchard Therapeutics PLC.

Orchard Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Orchard Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Orchard Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Orchard Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Orchard Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Orchard Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Orchard Therapeutics' historical news coverage. Orchard Therapeutics' after-hype downside and upside margins for the prediction period are 16.51 and 16.89, respectively. We have considered Orchard Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
After-hype Price
Orchard Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Orchard Therapeutics PLC is based on 3 months time horizon.

Orchard Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Orchard Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Orchard Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Orchard Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
6 Events / Month
4 Events / Month
In about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Orchard Therapeutics Hype Timeline

Orchard Therapeutics PLC is now traded for 16.70. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Orchard anticipated not to react to the next headline with the price going to stay at about the same level and average media hype impact volatility of over 100%. The immediate return on the next newsis anticipated to be very small whereas the daily expected return is now at 0.08%. The volatility of relative hype elasticity to Orchard Therapeutics is about 1688.89%. The volatility of related hype on Orchard Therapeutics is about 1688.89% with expected price after next announcement by competition of 16.7. About 12.0% of the company outstanding shares are owned by corporate insiders. The book value of Orchard Therapeutics was now reported as 3.53. The company recorded a loss per share of 4.1. Orchard Therapeutics PLC had not issued any dividends in recent years. The entity had 1:10 split on the 10th of March 2023. Given the investment horizon of 90 days the next anticipated press release will be in about 6 days.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.

Orchard Therapeutics Related Hype Analysis

Having access to credible news sources related to Orchard Therapeutics' direct competition is more important than ever and may enhance your ability to predict Orchard Therapeutics' future price movements. Getting to know how Orchard Therapeutics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Orchard Therapeutics may potentially react to the hype associated with one of its peers.

Orchard Therapeutics Additional Predictive Modules

Most predictive techniques to examine Orchard price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Orchard using various technical indicators. When you analyze Orchard charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Orchard Therapeutics Predictive Indicators

The successful prediction of Orchard Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Orchard Therapeutics PLC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Orchard Therapeutics based on analysis of Orchard Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Orchard Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Orchard Therapeutics's related companies.

Story Coverage note for Orchard Therapeutics

The number of cover stories for Orchard Therapeutics depends on current market conditions and Orchard Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Orchard Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Orchard Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Orchard Therapeutics Short Properties

Orchard Therapeutics' future price predictability will typically decrease when Orchard Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Orchard Therapeutics PLC often depends not only on the future outlook of the potential Orchard Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Orchard Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding12.8 M
Cash And Short Term Investments143.8 M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Consideration for investing in Orchard Stock

If you are still planning to invest in Orchard Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orchard Therapeutics' history and understand the potential risks before investing.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Content Syndication
Quickly integrate customizable finance content to your own investment portal